BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 Outsourced Pharma CDMO Leadership Award in the category of biologics.

Nonpharmacologic pain intervention provides benefits to people with dialysis-dependent kidney failure

Among people with dialysis-dependent kidney failure, a form of psychological therapy called pain coping skills training reduced how much pain got in the way of

December 31, 2024

Truveta Unveils Largest Mother-Child EHR Dataset for Pregnancy and Pediatric Research

What You Should Know: – Truveta, a data company dedicated to “Saving Lives with Data,” announced today the launch of the most comprehensive mother-child electronic

April 27, 2024

Fosravuconazole by Eisai for Tinea Pedis (Athlete Foot): Likelihood of Approval

Fosravuconazole is under clinical development by Eisai and currently in Phase II for Tinea Pedis (Athlete Foot).

December 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.